SCHEMBL19009747

SCHEMBL19009747

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4nc5c6ccccc6c6ccccc6c5c5ccncc45)cc3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 6/20 0.45
CSNK2B P67870 6/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ATM Q13315 1/20 0.44
TNF P01375 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
DHODH Q02127 2/20 0.38
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
GLA P06280 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
PDE5A O76074 2/20 0.36
LATS1 O95835 1/20 0.36
AKT1 P31749 2/20 0.36
TGFBR1 P36897 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19009828 0.96 CSNK2A2 (0.47) CSNK2A2CSNK2BMEN1KMT2AATM
SCHEMBL17914955 0.92 MEN1 (0.42) CSNK2A2CSNK2BMEN1KMT2AATM
SCHEMBL17914957 0.89 CSNK2A2 (0.44) CSNK2A2CSNK2BMEN1KMT2AATM
SCHEMBL17915349 0.87 MEN1 (0.53) MEN1KMT2AATMALDH1A1TSHR
SCHEMBL19009738 0.86 CYP11B1 (0.43) CSNK2A2CSNK2BMEN1KMT2ASMN1; SMN2
SCHEMBL17915367 0.85 MEN1 (0.51) MEN1KMT2AATMDHODHALDH1A1
SCHEMBL17915350 0.85 MEN1 (0.51) MEN1KMT2AATMDHODHALDH1A1
SCHEMBL17915334 0.84 MEN1 (0.41) CSNK2A2CSNK2BMEN1KMT2AATM
SCHEMBL17914958 0.83 ALDH1A1 (0.40) CSNK2A2CSNK2BMEN1KMT2ATNF
SCHEMBL19009746 0.83 CYP11B1 (0.43) CSNK2A2CSNK2BDHODHALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170179407-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20170179407-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170179407-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CSNK2A2 1398/4885CSNK2B 1529/4885MEN1 611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.